Solid phase process for synthesizing peptides
AssigneeAlpha-1 Biomedicals, Inc.
InventorSu S. Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlpha-1 Biomedicals, Inc.
InventorSu S. Wang
Estimating the term…
Thymosin .alpha.1 and other peptide amides are synthesized in the solid phase using methylbenzhydrylamine resin as the support and hydrogen bromide as the deprotecting and cleaving agents. The N-terminal 14 amino acid partial sequence of thymosin .alpha.1, Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-OH is synthesized on benzyl ester resin. Using a mixture of hydrogen bromide, anisole and thioanisole as the cleavage and deprotection composition, the yields of the cleaved peptide and the selectivity of the deprotection is highly improved. For example, yields of thymosin .alpha.1 have been increased by about 90% as compared to the use of hydrogen bromide alone. By using hydrogen bromide rather than hydrogen fluoride, the synthesis can use conventional laboratory glassware and the synthesis can be easily scaled up to commercial production.
In a solid phase peptide synthesis process for producing a peptide amide having the amino acid sequence represented by the formula
In a solid phase peptide synthesis process for producing a peptide of a desired amino acid sequence by the steps of (a) temporarily chemically protecting the reactive amino group and any other reactive groups, other than the carboxylic acid group at the alpha-position, on the C-terminal amino acid of the peptide;
In a solid phase synthesis of the thymosin .alpha..sub.1, polypeptide having the sequence:
In a solid phase synthesis of the N-terminal 14 amino acid partial sequence of thymosin .alpha..sub.1 having the following sequence:
Dependencies are inferred from the claim text.